SY

Seethalakshmi Yeddanapudi

Director Director DIN 01924161
DIN 01924161 First appointment Sep 2007 Primary industry Real Estate and Construction
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2007
Shareholding value •••• Premium profile

About Seethalakshmi Yeddanapudi

Data last updated:

Seethalakshmi Yeddanapudi was a Director at Mahathi Estates Private Limited (2007–2009) and Director at Dr.Zygmet Pharma Private Limited (2007–2009). The companies operate in Real Estate and Construction and Chemicals.

DIN 01924161
Primary Designation Director
Industry Real Estate and Construction
First Appointment 05 Sep 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mahathi Estates Private Limited U70102TG2001PTC037778
Director05 Sep 20072001Converted To Llp
Dr.Zygmet Pharma Private Limited U24239TG2003PTC040946
Director05 Sep 20072003Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mahathi Estates Private Limited
Dr.Zygmet Pharma Private Limited
Premium access

Shareholding and investment profile for Seethalakshmi Yeddanapudi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seethalakshmi Yeddanapudi

Seethalakshmi Yeddanapudi was first appointed on 05 Sep 2007 as Director at Mahathi Estates Private Limited.

Seethalakshmi Yeddanapudi held 2 earlier board appointments: Mahathi Estates Private Limited (Director, 05 Sep 2007 to 04 Nov 2009); Dr.Zygmet Pharma Private Limited (Director, 05 Sep 2007 to 04 Nov 2009).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available